The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CANCAP02: A study into the pharmacodynamic biomarker effects of vistusertib (AZD2014), an mTORC1/2 inhibitor, given prior to radical prostatectomy (RP).
 
Simon Pacey
Research Funding - AstraZeneca
 
Javier Garcia Corbacho
No Relationships to Disclose
 
Nimish Shah
No Relationships to Disclose
 
Ola Bratt
No Relationships to Disclose
 
Anne Warren
No Relationships to Disclose
 
Richard D. Baird
Consulting or Advisory Role - Shionogi
Research Funding - AstraZeneca (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Genentech (Inst); Molecular Partners (Inst); Roche (Inst); Sanofi (Inst); Shionogi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Molecular Partners; Shionogi
 
Vincent Gnanapragasam
No Relationships to Disclose
 
Sara Stearn
No Relationships to Disclose
 
Susan Ingle
No Relationships to Disclose
 
Leanne K Bell
No Relationships to Disclose
 
William Dott
No Relationships to Disclose
 
Wendi Qian
No Relationships to Disclose
 
Wanfeng Zhao
No Relationships to Disclose
 
Barry Davies
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Elizabeth A. Harrington
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Elisabeth Maria Oelmann
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Mirela Hategan
No Relationships to Disclose
 
Sanjeev Kumar
No Relationships to Disclose